Treatment Pathway

Treatment of Streptococcal Pharyngitis (Strep Throat)

Strep throat is a bacterial infection of the throat caused by Group A Streptococcus, causing sore throat, fever, and swollen tonsils. Antibiotic treatment prevents rare but serious complications including rheumatic fever and kidney disease.

NICE (UK)WHO Clinical GuidelinesAAFP (American Academy of Family Physicians)BMJ Best Practice
SymptomsCausesTreatmentWhen to See a DoctorRelated Questions

Managing Streptococcal Pharyngitis (Strep Throat) effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Streptococcal Pharyngitis (Strep Throat) can maintain a good quality of life and prevent serious complications.

First-Line Treatment Principles

What to Do Now

  1. Learn your personal risk factors for Streptococcal Pharyngitis (Strep Throat) (family history, age, lifestyle)
  2. Attend regular health check-ups and screening tests appropriate for your age and risk
  3. Track new or changing symptoms, especially those associated with Streptococcal Pharyngitis (Strep Throat)
  4. Use our AI symptom checker to assess whether your symptoms fit an early Streptococcal Pharyngitis (Strep Throat) pattern
  5. Discuss preventive strategies and early monitoring with your GP
  6. Build a personalised management plan with your GP or specialist
  7. Adhere consistently to prescribed medications — do not stop without medical advice
  8. Adopt a Streptococcal Pharyngitis (Strep Throat)-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)

Medications Used in Streptococcal Pharyngitis (Strep Throat)

AmoxicillinPenicillin Antibiotic

Amoxicillin is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.

Amoxicillin ClavulanatePenicillin Antibiotic

Amoxicillin Clavulanate is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.

AmpicillinPenicillin Antibiotic

Ampicillin is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.

PiperacillinPenicillin Antibiotic

Piperacillin is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.

FlucloxacillinPenicillin Antibiotic

Flucloxacillin is a narrow-spectrum, penicillinase-resistant penicillin antibiotic active mainly against Gram-positive bacteria such as Staphylococcus aureus and streptococci. It is used for skin and soft-tissue, bone and joint, and other staphylococcal infections. It has essentially no activity against the Gram-negative bacteria (such as E. coli) that cause most urinary tract infections, so it is not used to treat UTIs.

DicloxacillinPenicillin Antibiotic

Dicloxacillin is a narrow-spectrum, penicillinase-resistant penicillin antibiotic active mainly against Gram-positive bacteria such as Staphylococcus aureus. It is used for skin and soft-tissue and other staphylococcal infections. It has essentially no activity against the Gram-negative bacteria (such as E. coli) that cause most urinary tract infections, so it is not used to treat UTIs.

PhenoxymethylpenicillinPenicillin Antibiotic

Phenoxymethylpenicillin (penicillin V) is a narrow-spectrum oral penicillin antibiotic used mainly for streptococcal infections such as strep throat and for prophylaxis (e.g. rheumatic fever, asplenia). It has poor activity against the Gram-negative uropathogens (such as E. coli) that cause most urinary tract infections and is not a recommended treatment for UTIs.

BenzylpenicillinPenicillin Antibiotic

Benzylpenicillin (penicillin G) is a narrow-spectrum injectable penicillin antibiotic used for streptococcal, meningococcal and other susceptible Gram-positive infections. It is not standard therapy for typical urinary tract infections, which are usually caused by Gram-negative bacteria such as E. coli; its main urinary niche is a Group B Streptococcus (GBS) UTI, an uncommon and specific context.

Non-Pharmacological Management

Treatment Goals

🎯Symptom control and quality-of-life improvement
🎯Prevention of complications and disease progression
🎯Minimise treatment burden and adverse effects
🎯Patient-centred shared decision making

Monitoring Parameters

Red Flags — When to Escalate

Escalation Criteria

Special Populations

Elderly: polypharmacy risk, renal/hepatic dose adjustments, falls risk assessment
Pregnancy: check safety of all medications; specialist review if on multiple agents
Children: weight-appropriate dosing; developmental monitoring

Clinical Insights

Compare With Similar Conditions

Not sure about your symptoms?

Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.

Use AI Symptom Checker →